Paradigm’s Matt Huang: Led by SBF To Believe Alameda Did Not Have Privileged Treatment
Crypto News

Paradigm’s Matt Huang: Led by SBF To Believe Alameda Did Not Have Privileged Treatment

1m
Created 1yr ago, last updated 1yr ago

During his testimony on the third day of SBF's fraud trial, Paradigm co-founder Matthew Huang revealed Bankman-Fried resisted investor board seats at FTX.

Paradigm’s Matt Huang: Led by SBF To Believe Alameda Did Not Have Privileged Treatment

Paradigm’s Matt Huang: SBF Made Him Believe That Alameda Did Not Have Privileged Treatment

During his testimony on the third day of SBF's fraud trial, Paradigm co-founder Matthew Huang revealed Bankman-Fried resisted investor board seats at FTX. Huang engaged with SBF before Paradigm's $125 million stake in FTX's $900 million funding round, and claimed that SBF believed that having investors on FTX’s board of directors would not bring much benefits.
While concerned over lack of structure and FTX's relationship with Alameda, Huang said the rapid growth of the crypto exchange misled investors, including venture capital firms like Paradigm, Temasek, Sequoia and BlackRock.
Huang claimed SBF assured him that Alameda received no preferential treatment from FTX, contradicting earlier testimony that Alameda had unlimited access to customer funds. If he was told deposits backed Alameda bets, Huang said his investment decision would have changed as customer money is "sacred."


Let us know what you loved about this article, what could be improved, or share any other feedback by filling out this short form.
This article contains links to third-party websites or other content for information purposes only (“Third-Party Sites”). The Third-Party Sites are not under the control of CoinMarketCap, and CoinMarketCap is not responsible for the content of any Third-Party Site, including without limitation any link contained in a Third-Party Site, or any changes or updates to a Third-Party Site. CoinMarketCap is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement, approval or recommendation by CoinMarketCap of the site or any association with its operators. This article is intended to be used and must be used for informational purposes only. It is important to do your own research and analysis before making any material decisions related to any of the products or services described. This article is not intended as, and shall not be construed as, financial advice. The views and opinions expressed in this article are the author’s [company’s] own and do not necessarily reflect those of CoinMarketCap.
0 people liked this article